Pharmaceutical Works Polpharma competitive analysis

Latest publications and patents of Pharmaceutical Works Polpharma New

Explore the latest publications and patents granted to Pharmaceutical Works Polpharma, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Pharmaceutical Works Polpharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Methods Of Treating Inflammatory And Autoimmune Diseases With NatalizumabBIOGEN IDEC MASep 20, 2018
Assay For Jc Virus AntibodiesBIOGEN IDEC MAAug 27, 2018
Methods And Products For Evaluating An Immune Response To A Therapeutic AgentBIOGEN IDEC MAMar 9, 2018

Latest PTAB cases involving Pharmaceutical Works Polpharma

Discover the latest PTAB cases involving Pharmaceutical Works Polpharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Pharmaceutical Works Polpharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
PHARMACEUTICAL WORKS POLPHARMA3 - - - Highly Aggressive
BIOGEN IDEC MA - 29 - 1Non-Active
BIOGEN MA - 51 - 7Non-Active
ELAN PHARMACEUTICALS - 3 - - Non-Active